|
Market Closed -
Other stock markets
|
After hours 18:31:55 | |||
| 4.218 EUR | -3.87% |
|
4.071 | -3.49% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Development and Commercialization of Prophylactic Vaccines | - | - | - | 154M | 170M | |||||
Total Assets | - | - | - | 460M | 500M | |||||
Interest Expense | - | - | - | -23.32M | -23.98M | |||||
Income Tax Expense | - | - | - | 2.8M | 761K | |||||
CAPEX | - | - | - | -14.23M | -13.86M | |||||
EBT | - | - | - | -98.63M | -11.49M | |||||
D&A | - | - | - | 14.32M | 1.92M | |||||
Operating Income | - | - | - | -82.09M | 13.33M | |||||
Net Income | - | - | - | -101M | -12.25M | |||||
COVID | - | 253M | 310M | - | - | |||||
Operating Income | - | 3.93M | -42.84M | - | - | |||||
Pharmaceutical Products | ||||||||||
Vaccine Candidates | 31.6M | 3.26M | 5.56M | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | -47.17M | -55.02M | -31.89M | - | - | |||||
Technologies and Services | 12.78M | 28.51M | -39.09M | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | 931K | -3.88M | -50.88M | - | - | |||||
Commercialized Products | 65.94M | 63M | 85.25M | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | -11.13M | -1.47M | 19.57M | - | - | |||||
Operating Income | 2.25M | -4.94M | -7.41M | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 36.41M | 40.34M | 21.99M | 32.61M | 48.59M | |||||
Total Assets | 93K | 66K | 64K | 934K | 781K | |||||
Canada | 8.96M | 4.23M | 18.9M | 28.19M | 32.32M | |||||
Total Assets | 98K | 239K | 183K | 166K | 138K | |||||
United Kingdom | 1.85M | 2.71M | 10.9M | 20.22M | 19.49M | |||||
Total Assets | 21.98M | 87.39M | 84.84M | 87.65M | 93.31M | |||||
Germany | 7.06M | 726K | 20.34M | 13.24M | 18.37M | |||||
Austria | 3.33M | 9.34M | 13.75M | 13.92M | 15.9M | |||||
Total Assets | 58.9M | 61.24M | 52.2M | 49.46M | 48.53M | |||||
Nordics | 2.87M | 2.44M | 8.56M | 12.43M | 13.94M | |||||
Total Assets | 27.54M | 53.02M | 40.25M | 39.11M | 36.26M | |||||
Other Europe | 2.07M | 3.08M | 6.24M | 8.17M | 9.06M | |||||
Total Assets | 4.96M | 4.58M | 5.21M | 4.84M | - | |||||
France | - | - | 2.62M | 5.3M | 7.22M | |||||
Total Assets | - | - | - | - | 4.35M | |||||
Rest Of World | 3.38M | 134K | 11.48M | 10.56M | 4.69M | |||||
Switzerland | - | - | - | - | - | |||||
Other | - | - | - | - | - | |||||
North America | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Europe without France | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - |
- Stock Market
- Equities
- VLA Stock
- Financials Valneva
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition